Overview
- Times Radio hosted a live debate on November 20 between Helen Webberley and Helen Joyce, with Jo Coburn moderating a clash over medical treatment for gender-distressed youth.
- In a video from Washington, D.C., Webberley said "GenderGP has arrived right here in America" and advertised access to prescriptions from American physicians for $29.99 a month.
- The General Medical Council revoked Webberley’s licence to practise in 2024, and a 2022 MPTS ruling said she ran an unregistered online clinic and put patients at unwarranted risk of harm.
- A High Court judgment reported last year found a GenderGP testosterone regimen for a 15-year-old drove levels "dangerously high," leaving the child at risk of sudden death from thromboembolic disease.
- GenderGP operates offshore as a subscription telemedicine business registered in Singapore that facilitates access to puberty blockers and cross-sex hormones, while the NHS ended blockers for under‑18s and later extended a ban to private clinics following the Cass review’s finding of a weak evidence base.